MeSH term
Frequency | Condition_Probility | Humans | 22 | 0.0 |
Animals | 17 | 0.0 |
DNA Repair/*genetics | 3 | 0.0 |
Mutation | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Apoptosis | 2 | 0.0 |
*Cell Cycle Proteins | 12 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
Cyclins/metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Nucleosomes/metabolism | 2 | 4.0 |
Protein Binding | 4 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Transfection | 2 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Ultraviolet Rays | 5 | 0.0 |
Mice | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Cisplatin/pharmacology | 2 | 1.0 |
Proteins/*genetics | 2 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Female | 6 | 0.0 |
Male | 6 | 0.0 |
Sex Factors | 2 | 0.0 |
Apoptosis/physiology | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Protein p53/genetics/metabolism | 2 | 2.0 |
Transcription, Genetic | 3 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Base Sequence | 2 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
DNA Damage | 2 | 0.0 |
Dose-Response Relationship, Radiation | 3 | 0.0 |
Models, Genetic | 2 | 0.0 |
Molecular Sequence Data | 2 | 0.0 |
Protein p53/metabolism | 3 | 0.0 |
Cell Cycle Proteins/*genetics | 2 | 1.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
*DNA Damage | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 2 | 0.0 |
Nuclear Proteins/*metabolism | 3 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Adult | 3 | 0.0 |
Middle Aged | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Blotting, Western | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
DNA Repair | 2 | 0.0 |
